生物人工心脏瓣膜：升级一项已有50年历史的技术。
Bioprosthetic Heart Valves: Upgrading a 50-Year Old Technology.
作者信息
Li Kan Yan Chloe
机构信息
Institute of Cardiovascular Science, University College London, London, United Kingdom.
出版信息
Front Cardiovasc Med. 2019 Apr 11;6:47. doi: 10.3389/fcvm.2019.00047. eCollection 2019.
Abstract
Prosthetic heart valves have been commonly used to address the increasing prevalence of valvular heart disease. The ideal prosthetic heart valve substitute should closely mimic the characteristics of a normal native heart valve. Despite the development of various interventions, an exemplary valve replacement does not exist. This review provides an overview of the novel engineering valve designs and explores emergent immunologic insights into age-dependent structural valve degeneration (SVD).
摘要
人工心脏瓣膜已被广泛用于应对日益增多的心脏瓣膜病。理想的人工心脏瓣膜替代品应紧密模仿正常天然心脏瓣膜的特性。尽管已开展了各种干预措施，但仍不存在堪称典范的瓣膜置换物。本综述概述了新型工程瓣膜设计，并探讨了针对年龄依赖性结构性瓣膜退变（SVD）的新出现的免疫学见解。
相似文献
1
Bioprosthetic Heart Valves: Upgrading a 50-Year Old Technology.生物人工心脏瓣膜：升级一项已有50年历史的技术。
Front Cardiovasc Med. 2019 Apr 11;6:47. doi: 10.3389/fcvm.2019.00047. eCollection 2019.
2
Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.使用新的欧洲定义评估经导管主动脉生物瓣的长期结构退化。
Circ Cardiovasc Interv. 2019 Apr;12(4):e007597. doi: 10.1161/CIRCINTERVENTIONS.118.007597.
3
Tissue Valve Degeneration and Mechanical Valve Failure.组织瓣膜退变与机械瓣膜故障
Curr Treat Options Cardiovasc Med. 2019 Jun 14;21(7):33. doi: 10.1007/s11936-019-0735-2.
4
Mechanical versus bioprosthetic aortic valve replacement.机械瓣与生物瓣主动脉瓣置换术的比较。
Eur Heart J. 2017 Jul 21;38(28):2183-2191. doi: 10.1093/eurheartj/ehx141.
5
Glycation and Serum Albumin Infiltration Contribute to the Structural Degeneration of Bioprosthetic Heart Valves.糖基化和血清白蛋白浸润导致生物人工心脏瓣膜结构退变。
JACC Basic Transl Sci. 2020 Aug 5;5(8):755-766. doi: 10.1016/j.jacbts.2020.06.008. eCollection 2020 Aug.
6
Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.激活的组织重塑能否被视为瓣膜进行性退变的早期标志物？天然退变主动脉瓣及生物瓣置换术后检查点和细胞外基质重塑基因表达的比较分析。
Amino Acids. 2007 Jan;32(1):109-14. doi: 10.1007/s00726-006-0376-0. Epub 2006 Aug 2.
7
Polymeric prosthetic heart valves: A review of current technologies and future directions.聚合物人工心脏瓣膜：当前技术与未来方向综述
Front Cardiovasc Med. 2023 Mar 9;10:1137827. doi: 10.3389/fcvm.2023.1137827. eCollection 2023.
8
Transcatheter tissue engineered heart valves.经导管组织工程心脏瓣膜。
Expert Rev Med Devices. 2014 Jan;11(1):15-21. doi: 10.1586/17434440.2014.864231. Epub 2013 Nov 26.
9
Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition.采用新的欧洲共识定义评估经导管主动脉生物瓣球囊扩张瓣的结构性瓣膜衰败。
EuroIntervention. 2018 Jun 8;14(3):e264-e271. doi: 10.4244/EIJ-D-18-00015.
10
In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.寻找理想的瓣膜：优化基因修饰以预防生物瓣退化。
Ann Thorac Surg. 2019 Aug;108(2):624-635. doi: 10.1016/j.athoracsur.2019.01.054. Epub 2019 Mar 2.
引用本文的文献
1
Rethinking mechanical heart valves in the aortic position: new paradigms in design and testing.重新审视主动脉位置的机械心脏瓣膜：设计与测试的新范式
Front Cardiovasc Med. 2025 Jan 30;11:1458809. doi: 10.3389/fcvm.2024.1458809. eCollection 2024.
2
Durability of transcatheter aortic valve implantation.经导管主动脉瓣植入术的耐久性。
EuroIntervention. 2024 Jul 15;20(14):e845-e864. doi: 10.4244/EIJ-D-23-01050.
3
Monomeric glutaraldehyde fixation and amino acid detoxification of decellularized bovine pericardium for production of biocompatible tissue with tissue-guided regenerative potential.用于生产具有组织引导再生潜力的生物相容性组织的去细胞牛心包的单体戊二醛固定和氨基酸解毒处理
Heliyon. 2023 Sep 1;9(9):e19712. doi: 10.1016/j.heliyon.2023.e19712. eCollection 2023 Sep.
4
Calcification of Various Bioprosthetic Materials in Rats: Is It Really Different?大鼠体内各种生物假体材料的钙化：真的有不同吗？
Int J Mol Sci. 2023 Apr 14;24(8):7274. doi: 10.3390/ijms24087274.
5
Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review).双膦酸盐作为生物瓣钙化潜在抑制剂的研究进展（综述）。
Sovrem Tekhnologii Med. 2022;14(2):68-78. doi: 10.17691/stm2022.14.2.07. Epub 2022 Mar 28.
6
The hybrid crosslinking method improved the stability and anti-calcification properties of the bioprosthetic heart valves.混合交联方法提高了生物人工心脏瓣膜的稳定性和抗钙化性能。
Front Bioeng Biotechnol. 2022 Sep 9;10:1008664. doi: 10.3389/fbioe.2022.1008664. eCollection 2022.
7
Commentary: Rainmaking the "next-generation transcatheter aortic valve implantation" by anointing multidisciplinary perceptions.评论：通过融合多学科认知为“下一代经导管主动脉瓣植入术”带来突破
JTCVS Open. 2020 Jul 7;3:25-26. doi: 10.1016/j.xjon.2020.07.001. eCollection 2020 Sep.
8
Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.生物人工心脏瓣膜钙化的机制与药物治疗
Front Pharmacol. 2022 Jun 3;13:909801. doi: 10.3389/fphar.2022.909801. eCollection 2022.
9
Natural Polymers in Heart Valve Tissue Engineering: Strategies, Advances and Challenges.心脏瓣膜组织工程中的天然聚合物：策略、进展与挑战
Biomedicines. 2022 May 8;10(5):1095. doi: 10.3390/biomedicines10051095.
10
Yak Pericardium as an Alternative Biomaterial for Transcatheter Heart Valves.牦牛心包作为经导管心脏瓣膜的替代生物材料。
Front Bioeng Biotechnol. 2021 Nov 8;9:766991. doi: 10.3389/fbioe.2021.766991. eCollection 2021.
本文引用的文献
1
B4GALNT2 and xenotransplantation: A newly appreciated xenogeneic antigen.B4GALNT2 与异种移植：一种新发现的异种抗原。
Xenotransplantation. 2018 Sep;25(5):e12394. doi: 10.1111/xen.12394. Epub 2018 Mar 31.
2
Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.低手术风险患者经导管主动脉瓣置换术与外科主动脉瓣置换术的比较：随机试验和倾向评分匹配观察性研究的荟萃分析
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):408-416. doi: 10.1002/ccd.27518. Epub 2018 Feb 1.
3
Heart valve tissue engineering: an overview of heart valve decellularization processes.心脏瓣膜组织工程：心脏瓣膜去细胞化过程综述
Regen Med. 2018 Jan;13(1):41-54. doi: 10.2217/rme-2017-0061. Epub 2018 Jan 23.
4
Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes.新一代生物瓣主动脉瓣置换术后的主要安全性和有效性可行性研究：一年结果。
Kardiol Pol. 2018;76(3):618-624. doi: 10.5603/KP.a2017.0262. Epub 2018 Jan 3.
5
Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.用于主动脉瓣和二尖瓣置换的机械或生物假体
N Engl J Med. 2017 Nov 9;377(19):1847-1857. doi: 10.1056/NEJMoa1613792.
6
Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?经导管主动脉瓣植入术在低危患者中的应用：前景如何？
Eur Heart J. 2018 Feb 21;39(8):658-666. doi: 10.1093/eurheartj/ehx489.
7
Pacemaker implantation after TAVI: predictors of AV block persistence.经 TAVI 后植入起搏器：房室传导阻滞持续存在的预测因素。
Clin Res Cardiol. 2018 Jan;107(1):60-69. doi: 10.1007/s00392-017-1158-2. Epub 2017 Sep 29.
8
The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue.COMMENCE 试验：带 RESILIA 组织的主动脉生物瓣 2 年结果。
Eur J Cardiothorac Surg. 2017 Sep 1;52(3):432-439. doi: 10.1093/ejcts/ezx158.
9
Mechanical versus bioprosthetic aortic valve replacement.机械瓣与生物瓣主动脉瓣置换术的比较。
Eur Heart J. 2017 Jul 21;38(28):2183-2191. doi: 10.1093/eurheartj/ehx141.
10
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.中危患者的外科手术或经导管主动脉瓣置换术。
N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17.
Zotero 插件